Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in the Treatment of Methamphetamine Use Disorder
NCT07774702Phase 2Not yet recruiting
- Start
- Feb 2027
- Primary completion
- Feb 2032
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in methamphetamine use disorder (MUD). Planned start Feb 2027; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT07774702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07774702.